04/28/09
Ocera Therapeutics Presents Data on AST-120 in Patients with Hepatic Encephalopathy at the European Association for the Study of Liver Disease Annual Meeting
04/01/09
Ocera and UCL Complete Licensing of Novel Treatment of Acute Hepatic Encephalopathy
03/16/09
Jeffrey D. Bornstein, M.D. Joins Ocera Therapeutics, Inc. as Vice President, Clinical Development and Medical Affairs
02/27/08
M. Scott Harris, M.D., Joins Ocera Therapeutics, Inc., as Chief Medical Officer